Kymera Therapeutics, Inc. — Form 4
Filed October 1, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
Chief Executive Officer Mainolfi Nello (KYMR) sold 60K shares (~$3.4M) on the open market (50% of holdings). Large sale — ~50% of holdings.
Why this rating
Large sale — ~50% of holdings.
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.